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Takotsubo Cardiomyopathy
Aimee Baker BSN, RN, CCRN
Otterbein University, Westerville, Ohio
What Topic?
Takotsubo Cardiomyopathy (TTC)
•
First discovered in Japan in the
1990’s, TTC represents a transient
type of left ventricular wall
dysfunction.
•
TTC gets its name from the shape
that the left ventricle (LV) takes on
during apical ballooning.
•
Tatkotsubo comes from the
Japanese words meaning octopus
(takot) and jar (subo). (See figure
3)
•
TTC has a frequency of 5.2 per
100,000 females and 0.6 per
100,000 males. (Agarwal et al.,
2017)
•
2-3% of ST-segment Elevated
Myocardial Infarction (STEMI) in
women are actually TTC. (Sattar et
al., 2020)
•
TTC is associated with a physical or
emotional trigger which stimulates
a massive catecholamine release
mediated by the sympathetic
nervous system. (Chen & Dilsizian,
2017)

Why TTC?
Clinicians must differentiate TTS from
other acute coronary syndrome
disorders. Although TTC presents similar
to an acute myocardial infarction,
patients do not have evidence of ischemia
on cardiac catheterization. (Sattar et al.,
2020)
A recent systematic review and metaanalysis suggests a possible correlation
with surgery and TTC. (Agarwal et al,
2017) Nurse anesthesia providers must
include TTC in the differential diagnosis
upon encountering acute coronary
syndrome like events in the operating
room.
Regardless of how TTC develops,
Advanced Practice Registered Nurses
must understand how diagnosis nuances
may affect care. Although current
treatment recommendations are similar
to many Heart Failure treatment
recommendations, certain TTC associated
complications provide treatment
nuances. (Sattar et al., 2017)
People who develop TTC may have
long-term physical and structural
impairment after LVEF recovery. (Scally
et al., 2018) These changes may
represent a new phenotype of heart
failure. (Scally et al., 2018) Lastly, TTC
disproportionately affects women which
represent 90% of all cases. (Pellicca et al.,
2017)

Understanding Pathophysiology
Chen and Dilsizian (2017) describe
two leading in-depth hypotheses of TTC
pathogenesis. The first hypothesis is that
there is a regional myocardial stunning
due to a transient vascular dysfunction
such as coronary vasospasm,
microvascular dysfunction, or aborted
myocardial infarction. (Chen & Dilsizian,
2017) Myocardial stunning is thought to
be a metabolic adaptation that inhibits
glucose utilization despite blood flow
returning to normal. (Chen & Dilsizian,
2017) These metabolic alterations
appear to be most pronounced during
the acute phase of TTC and resolve
during the recovery phase. (Chen &
Dilsizian, 2017)
The second hypothesis for
pathogenesis is that a cardiac
sympathetic innervation or disruption
occurs. (Chen & Dilsizian, 2017)
Researchers utilize Imetaiodobenzylguanidine (mIBG) as a
radiotracer analyzing cardiac
sympathetic activity and notice a
decrease in cardiac sympathetic
innervation in patients with TTC. (Chen
& Dilsizian, 2017) Researchers postulate
that the abnormal epinephrine and
norepinephrine serum concentrations
could cause a switch in the Beta-2
receptors to initiate Gi coupling instead
of normal Gs coupling. (Chen & Dilsizian,
2017) This temporary switch in theory
allows myocytes to recover inotropic
function. (Chen & Dilsizian, 2017)

TTC often has an identifiable
stress-producing event, physical or
emotional, associated with onset. This
event stimulates the sympathetic
nervous system via the limbic system
and induces excessive amount of
catecholamine release. (See figure 1)
Pelliccia, Kaski, Crea, and Camici
(2017) note that emotional stress
activates portions of the brain which
increase the bioavailability of cortisol,
epinephrine, and norepinephrine.
Additionally, endothelial dysfunction
is believed to contribute to
microvascular coronary artery spasms
in TTC through an imbalance of
vasodilating and vasoconstricting
factors. (Pellicca et al., 2017) Estrogen
is believed to be an endothelial and
cardiovascular protective hormone.
(Akashi et al., 2008) Therefore, a lack
of estrogen, present in postmenopause may explain why TTC is
more common in post-menopausal
women. (Pellica et al., 2017)(See
Figure 2) Endothelial tissue secrets
vasodilating and vasoconstricting
substances which therefore influences
myocardial perfusion. (Pellica et al.,
2017)
Chen and Dilszian (2017) expand
upon known pathophysiology and
postulate what happens at a cellular
level to further explain TTC
pathophysiology.
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Figure 1 Plasma catecholamine levels
in patients with TTC. (Massachusetts
Medical Society, 2005)

•

Chest pain (Agarwal et al., 2017)
Dyspnea (Agarwal et al., 2017)
Elevated troponin level (Agarwal et al.,
2017)
Electrocardiogram abnormalities
(Chen and Dilsizan, 2017)
ST-segment elevation (Agarwal et al.,
2017)
T-wave abnormalities (Agarwal et al.,
2017)
Less likely to see ST-segment elevation
and T-wave abnormalities in
perioperative TTC presentation
(Agarwal et al., 2017)
Apical rounding then basal and midventricular contraction on left ventricle
angiogram (Sattar et al., 2020)

Treatment Recommendations

Long-Term Prognosis

TTC with Cardiogenic Shock (without
left ventricular outflow tract
obstruction (LVOTO)) (Sattar et al.,
2020)
•
Cautious fluid resuscitation
•
Inotropic agent trial (dopamine or
dobutamine)
•
Intra-aortic balloon pump (IABP) for
persistent hypotension or signs of end
organ damage
•
Vasopressors contraindicated in
moderate to severe LVOTO

Treatment of TTC is focused on acute
management of symptoms. Sattar et al.
(2020) highlight treatment
recommendations for general
management, TTC without complications,
TTC with hypotension and cardiogenic
shock, TTC with Heart Failure, and TTC
with thromboembolism.
General Management (TTC without
Complications) (Sattar et al., 2020)
•
Emotional or physical stress
management
•
Dual antiplatelet therapy,
discontinue upon discharge
•
Angiotensin-converting enzyme
inhibitor (ACE)/angiotensin
receptor blocker (ARB)

TTC with Cardiogenic shock and LVOTO
(Sattar et al., 2020)
•
Inotropic agents contraindicated
•
Moderate to severe LVOTO-fluid
resuscitation
•
Beta blockers to improve LVOTO
gradient
•
May consider alpha agonist
•
IABP considered with caution in
patients not responsive to fluid
resuscitation
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Recent evidence suggests that TTC
may have long-term complications
despite LVEF recovery. Scally et al.
(2017) report statistically significant
variations in exercise capacity and
metabolic performance, LV functional
and structural variations, and cardiac
inflammatory biomarkers among
individuals recovered from TTC and
those who have not had TTC. Scally et al.
(2017) propose that their findings
represent a new phenotype of heart
failure secondary to TTC.
However, Scally et al. (2017) note
further research must establish a
causative relationship with their
observed changes.

Nursing Implications
Advanced practice nurses (APRNs)
must understand the pathophysiology of
TTC to provide excellent care. Nurse
Anesthetists in particular ought not
exclude TTC in the differential diagnosis
in a rapidly deteriorating patient.
Understanding the pathophysiology
of TTC guides APRN’s understanding of
TTC treatment modalities.
TTC, unlike other cardiovascular
pathologies, often has an emotional
trigger. Soube et al. (2017) reported that
31.7% of patients in their study had an
identifiable emotional trigger. Nurses are
uniquely prepared clinicians who can
blend medical diagnoses with caring
practices. APRNs must holistically
approach patients with a TTC diagnosis
to ensure that care meets a patient’s
physical and emotional needs.

Conclusion
Takotsubo Cardiomyopathy is a
recent discovery in cardiology. Because it
presents like acute coronary syndrome
yet acts like heart failure, clinicians must
understand TTC’s pathophysiology in
order to provide appropriate treatment.
(Sattar et al., 2017)
Unlike many cardiovascular
pathologies, TTC often has a direct link to
an emotional trigger. (Sobue et al., 2017)
Care must include emotional support
especially in instances where an
emotional trigger is identified. (Sattar et
al., 2017) Nurses are well prepared to
offer excellent, holistic care to this
population.
TTC needs further research to
develop current understanding. This is
most notable with long-term prognosis.
TTC was once considered resolved after
LVEF returned to normal. (Scally et al.,
2018) However, recent literature
suggests that there are long-term cellular
metabolic variations associated with TTC.
(Scally et al., 2018)
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Figure 2 Proposed model of TTC pathophysiology (Yoshihiro et al., 2008)

Treatment Continued
TTC with Heart Failure (Sattar et al.,
2020)
•
Oxygen and respiratory support as
needed
•
Preload and afterload reduction only
in cases without LVOTO
•
ACE inhibitor/ARB
•
Continue treatment until systolic
function improves, about four weeks

TTC with Thromboembolism (Sattar et
al., 2020)
•
Ventricular thrombus present in 1.3%
of patients with TTC
•
Anticoagulation for three months in
presence of LV thrombus
•
No clear guidelines to prevent LV
thrombus, ten days anticoagulation
recommended
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Figure 3 Systolic cardiac morphology in TTC compared to a Takotsubo or jar
for capturing octopus (Cesario et al., 2012)
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